Scott & Selber Inc. Purchases 7,964 Shares of The Clorox Company $CLX

Scott & Selber Inc. grew its stake in shares of The Clorox Company (NYSE:CLX) by 47.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,839 shares of the company’s stock after buying an additional 7,964 shares during the quarter. Scott & Selber Inc.’s holdings in Clorox were worth $2,574,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after buying an additional 514 shares during the period. Woodline Partners LP grew its holdings in shares of Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the last quarter. Baird Financial Group Inc. raised its stake in shares of Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after purchasing an additional 424 shares during the last quarter. Jump Financial LLC lifted its stake in Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after acquiring an additional 7,924 shares during the period. Finally, Bank of Nova Scotia lifted its position in Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after purchasing an additional 3,352 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CLX shares. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. Royal Bank Of Canada reduced their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Jefferies Financial Group dropped their target price on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Morgan Stanley dropped their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Finally, Barclays cut their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, Clorox currently has a consensus rating of “Reduce” and an average price target of $103.40.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.63% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $95.90 on Monday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The company’s 50 day moving average is $95.71 and its 200 day moving average is $104.81. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a market cap of $11.60 billion, a PE ratio of 15.57, a price-to-earnings-growth ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts forecast that The Clorox Company will post 5.61 EPS for the current year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.